Skip to main content
Premium Trial:

Request an Annual Quote

Organon and Shanghai Genomics Sign Receptor Research Deal

NEW YORK, Jan. 24 (GenomeWeb News) - Organon has secured the cooperation of Shanghai Genomics in the company's program to identify selective steroid hormone receptor modulators, Organon said today.

 

The research, which represents Organon's second major research project in China, will focus on rheumatoid arthritis, atherosclerosis, and oncology and will last two years, said Organon.

 

Financial details were not disclosed.

 

Shanghai Genomics was founded in August 2001. It merged with Tokyo-based Gene Networks International in June 2005.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.